Skip to Content

Guggenheim SMid Cap Value A SEVAX

Analyst rating as of

Morningstar’s Analysis

Will SEVAX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

A steady team, but high fees.

Summary

| |

Guggenheim Smid Cap Value benefits from a stable team of industry veterans, but an unexceptional approach and high fees limit all share classes to a Morningstar Analyst Rating of Neutral.

Unlock our full analysis with Morningstar Investor